Skip to main content
Year archive

Vaxil Bio Ltd. — 2018 filings

All 17 regulatory filings released by Vaxil Bio Ltd. (VXL) in 2018, sourced directly from the official regulator.

17 Filings
2018 Period
2018 filings (17)
Filing Released Lang
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2018-11-29 English
Interim MD&A - English.pdf
Regulatory Filings
2018-11-29 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2018-08-28 English
Interim MD&A - English.pdf
Regulatory Filings
2018-08-28 English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf
Regulatory Filings
2018-07-13 English
Interim financial statements/report (amended) - English.pdf
Regulatory Filings
2018-07-13 English
Management information circular - English.pdf
Regulatory Filings
2018-05-31 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2018-05-31 English
Interim MD&A - English.pdf
Regulatory Filings
2018-05-31 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2018-05-01 English
Annual MD&A - English.pdf
Regulatory Filings
2018-05-01 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2018-05-01 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2018-04-27 English
Material change report - English.pdf
Regulatory Filings
2018-02-26 English
News release - English.pdf
Regulatory Filings
2018-02-07 English
News release - English.pdf
Regulatory Filings
2018-02-07 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings
2018-02-05 English